Orthometrix FCF Yield
The Free Cash Flow Yield of Orthometrix (OMRX) as of Jul 29, 2026 is 437,749.00 %.
Get this data via API
Financial Data API
FCF Yield
437,749.00 %
Last updated:
Free Cash Flow Yield of Orthometrix is 2026 437,749.00 % . Free Cash Flow Yield of Orthometrix was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Orthometrix Stock analysis
What does Orthometrix do? Orthometrix Inc is a leading provider of medical devices and services in the field of orthopedics. The company was founded in 1986 and is headquartered in White Plains, New York. Orthometrix operates various business segments, including the development and manufacturing of medical devices, as well as the provision of services related to orthopedic conditions.
Orthometrix's business model is based on the development and manufacturing of medical devices that help diagnose and treat orthopedic conditions. In addition, the company also offers services related to orthopedic conditions, such as posture and gait analysis.
The different divisions of Orthometrix include diagnostics, rehabilitation, and medical devices. In the diagnostics area, Orthometrix offers a range of products that help diagnose orthopedic conditions. These include electromyography systems, which measure the electrical activity of muscles, as well as motion analysis systems that analyze posture, gait, and muscle function.
In the rehabilitation area, Orthometrix offers a wide range of products that help rehabilitate the musculoskeletal system. These include weights and bands that can improve muscle training, as well as biofeedback systems that provide feedback on muscle activity.
In the medical devices area, Orthometrix offers a range of devices that can be used to treat orthopedic conditions. These include knee braces that help improve knee protection, as well as hand and elbow braces that can be used to stabilize the wrist and elbow.
Orthometrix has also specialized in providing services related to orthopedic conditions. This includes posture and gait analysis, which can help diagnose and treat orthopedic problems. Orthometrix also offers training and continuing education for medical professionals to ensure they are up to date with developments in the field of orthopedics.
Overall, Orthometrix has achieved a leading position in the orthopedics field and is an important provider of medical devices and services for healthcare professionals and patients worldwide. With a wide range of products and services, Orthometrix has successfully established itself in the market and will continue to grow. Orthometrix is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Orthometrix stock
Free Cash Flow Yield of Orthometrix is 437,749.00 % in 2026.
Access this data via the Eulerpool API
Valuation — Orthometrix
All Key Metrics — Orthometrix
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth